Promising Study: Anarti's CBD Oil Shows Efficacy for Pain Relief

Anarti Therapeutics has shared promising data from an in vitro study on its Ayurvedic CBD Relief Oil. The Dabur Research Foundation conducted the study, which reveals a potential mechanism for how the oil alleviates chronic pain linked to fibromyalgia.

The primary aim was to assess the anti-inflammatory effects of the oil at a cellular level. Researchers focused on its impact on inflammatory markers and cytokine production. The study used human monocytes treated with the oil at different concentrations and measured pro-inflammatory cytokines like TNF-α, IL-6, and IL-8 using ELISA assays.

The findings showed a significant reduction in these cytokines, with no adverse effects on cell viability. This suggests the oil's anti-inflammatory properties are not due to cytotoxicity. The active ingredients, including CBD, contribute to these effects.

The study underscores the oil's potential as a natural anti-inflammatory agent. Anarti Therapeutics' CBD Relief Oil is now available online, offering an option for those managing inflammation and related conditions.

For more information, access the full study and product details on Anarti Therapeutics' website.